In addition to two future dermatologists, he is helping a pharmacist and an internist to navigate in the world of science, one of whom has already started writing her first publication. In May, Dr. Norbert Kiss was named Supervisor of the Month (Year 1) at the Centre for Translational Medicine.

The Department of Dermatology, Venereology and Dermatooncology has been collaborating with the CTM since its launch in Budapest, and Dr. Kiss found that the joint scientific work is of a very high quality, resulting in excellent publications. This motivated him to join the Centre as a supervisor last September.

„I have four first-year Ph.D. students, two of whom want to become a dermatologist, one is a pharmacist and one is an internist. One of the future dermatologists is researching teledermatology. She is comparing the diagnostic accuracy of this method to face-to-face examination in the diagnosis of skin diseases. She is also investigating the diagnostic accuracy of artificial intelligence systems. My other student is comparing the efficacy of imaging modalities for diagnosing malignant melanoma. Our clinic also conducts clinical trials of dermatological imaging techniques, so it’s useful for our colleagues that we’re doing a meta-analysis to review the trends in research around the world and explore which imaging techniques are the most innovative.”

The pharmacist student of Dr. Kiss is comparing the efficacy and safety of pharmacological therapies for advanced cutaneous squamous cell carcinoma in her Ph.D. research. Additionally, she is investigating the efficacy of preventive and therapeutic options for kinase inhibitory therapy-induced skin toxicity. Her aim is to find the most effective treatment and appropriate management of side effects in oncological patients. “My internist student is working on the immunological skin disease prurigo nodularis and its treatment. She is very interested in immunology and will soon start her training in immunology. Her other topic is also related to immunology: she is investigating the safety and efficacy of biologics in chronic spontaneous urticaria. All my students are progressing well with their topics, they have already finished data collection, and one of them has already started writing her first manuscript.”

(Szabó Emese)